Apimeds Pharmaceuticals US, Inc.
APUS
$1.75
-$0.06-3.32%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -99.15% | -96.46% | -- | 2,277.42% | 6,520.97% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -17.24% | -94.00% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -96.90% | -96.00% | -- | -- | 6,708.06% |
|
|
|||||
| Total Current Assets | -96.90% | -96.00% | -- | -- | 6,708.06% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -96.90% | -96.00% | -- | -- | 6,708.06% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 465.94% | 740.99% | -- | -- | 243.45% |
| Short-term Debt | -- | -20.63% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 730.74% | 101.91% | -- | -- | -61.44% |
|
|
|||||
| Total Current Liabilities | 730.74% | 101.91% | -- | -- | -61.44% |
| Long-Term Debt | 29.94% | -19.50% | -- | -- | -33.28% |
| Short-term Debt | -- | -20.63% | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 251.41% | 39.42% | -- | -- | -45.79% |
|
|
|||||
| Common Stock & APIC | 0.00% | 45.81% | -- | -- | 100.83% |
| Retained Earnings | -46.30% | -67.57% | -- | -- | -34.97% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4,357.37% | -818.26% | -- | 62.92% | 104.47% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4,357.37% | -818.26% | -- | 62.92% | 104.47% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4,357.37% | -818.26% | -- | 62.92% | 104.47% |
|
|
|||||